年轻母亲叶酸代谢基因多态性与唐氏综合征发生的关系
收稿日期: 2009-09-28
修回日期: 2010-03-06
网络出版日期: 2010-05-05
基金资助
安徽省高等学校省级自然科学研究项目(编号: KJ2009B084Z)和蚌埠医学院自然科学研究项目(编号: BY0709)资助
Folate gene polymorphism and the risk of Down syndrome pregnan-cies in young Chinese women
Received date: 2009-09-28
Revised date: 2010-03-06
Online published: 2010-05-05
为探讨年轻母亲叶酸代谢相关基因MTHFR 677C>T、MTRR 66A>G、RFC-1 80G>A和MTR 2756A>G多态性与唐氏综合征(Down syndrome, DS)发生的关系, 采用随机病例-对照研究设计, 应用PCR-RFLP方法检测60例DS患儿的母亲与68例正常生育女性的基因型。经χ2 检验, MTHFR基因T等位基因频率在病例组和对照组中差异有统计学意义(P<0.05), 而MTRR、MTR和 RFC-1等位基因频率差异无统计学意义。Logistic回归分析显示: 携带MTHFR TT基因型的母亲孕育DS患儿的风险显著增加(OR=3.51, 95% CI=1.30~9.46, P<0.05), 而杂合子CT以及CT合并TT基因型与DS发生风险无显著关联; 携带MTRR GG基因型的母亲孕育DS患儿的风险增加3.16倍(OR=3.16, 95% CI=1.20~8.35, P<0.05), 而RFC-1和MTR突变基因型与DS发生风险无显著关联; MTHFR(CT+TT)/MTRR GG、MTHFR (CT+TT)/ RFC-1 AA、MTHFR CC / MTR (AG +GG)、 MTHFR (CT+TT)/MTR AA、MTRR GG/MTR AA和RFC-1 AA / MTR AA联合基因型与DS发生风险显著相关。结果表明, 年轻女性MTHFR 677C>T、MTRR 66A>G位点变异是孕育DS患儿的独立风险因子, 尚不能认为RFC-1 80G>A、MTR 2756A>G多态性与DS发生相关, 而基因与基因多态位点之间存在交互和修饰效应。
廖亚平,鲍明升,刘长青,刘辉,张鼎 . 年轻母亲叶酸代谢基因多态性与唐氏综合征发生的关系[J]. 遗传, 2010 , 32(5) : 461 -466 . DOI: 10.3724/SP.J.1005.2010.00461
To explore the relationship between genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase reductase (MTRR), reduced folate carrier1 (RFC-1), methionine synthase (MTR) involved in folate metabolism and the risk of offsprings of young Chinese women with Down syndrome (DS) through a case-control study, the polymorphisms of MTHFR 677C>T, MTRR 66A>G, RFC-1 80G>A, and MTR 2756A>G in 60 mothers of children with DS and 68 control mothers were investigated by PCR-RFLP. Significant differences in alle-lic frequencies were present between the cases and controls for MTHFR (P<0.05), but not in allelic frequencies for MTRR, RFC-1, and MTR. Homozygous MTHFR 677C>T polymorphism was more prevalent among the mothers of children with DS than among the control mothers, with an odds ratio of 3.51 (OR=3.51, 95% CI=1.30~9.46, P<0.05). No significant association was observed in the combined heterozygotes. In addition, the homozygous MTRR 66A>G polymorphism was independently associated with a 3.16-fold increase in estimated risk (OR=3.16, 95% CI=1.20~8.35, P<0.05). The increased risk of DS for homozygous RFC-1 80G>A was not associated with MTR 2756A>G. Positive interactions were found for the following genotype-pairs: MTHFR(CT+TT)/MTRR GG, MTHFR (CT+TT)/RFC-1 AA, MTHFR CC/MTR(AG+GG), MTHFR (CT+TT)/MTR AA, MTRR GG/MTR AA, and RFC-1 AA/MTRAA. In conclusion, MTHFR 677C>T and MTRR 66A>G polymorphisms are two independent risk factors for DS pregnancies in young women, but RFC-1 80G>A and MTR 2756A>G polymorphism are not independent risk factor. A role for combined genotypes in the risk of DS pregnancies cannot be excluded.
Key words: Down syndrome; MTHFR; MTRR; RFC-1; MTR; polymorphism
[1] Migliore L, Boni G, Bernardini R, Trippi F, Colognato R, Fontana I, Coppedè F, Sbrana I. Susceptibility to chromo-some malsegregation in lymphocytes of women who had a Down syndrome child in young age. Neurobiol Aging, 2006, 27(5): 710–716.
[2] James SJ, Pogribna M, Pogribny IP, Melnyk S, Hine RJ, Gibson JB, Yi P, Tafoya DL, Swenson DH, Wilson VL, Gaylor DW. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be ma-ternal risk factorsfor Down syndrome. Am J Clin Nutr, 1999, 70(4): 495–501.
[3] Hobbs CA, Sherman SL, Yi P, Hopkins SE, Torfs CP, Hine RJ, Pogribna M, Rozen R, James SJ. Polymorphisms in genes involved in folate metabolism as maternal risk fac-tors for Down syndrome. Am J Hum Genet, 2000, 67(3): 623–630.
[4] Scala I, Granese B, Sellitto M, Salome S, Sammartino A, Pepe A, Mastroiacovo P, Sebastio G, Andria G. Analysis of seven maternal polymorphisms of genes involved in ho-mocysteine/folate metabolism and risk of Down syndrome offspring. Genet Med, 2006, 8(7): 409–416.
[5] Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in me-thylenetetrahydrofolate reductase. Nat Genet, 1995, 10(1): 111–113.
[6] Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP. A polymorphism (80G→A) in the reduced folate carrier gene and its asso-ciations with folate status and homocysteinemia. Mol Genet Metab, 2000, 70(4): 310–315.
[7] Bosco P, Gueant-Rodriguez RM, Anello G, Barone C, Namour F, Caraci F, Romano A, Romano C, Gueant JL. Methionine synthase (MTR) 2756 (A→G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome. Am J Med Genet A, 2003, 121(3): 219–224.
[8] 史庆华, 许波, 杨庆岭, 陈大蔚, 侯贺礼, 马铁梁, 郑媛. 非整倍体和人类生殖健康. 中国科学技术大学学报, 2008, 38(8): 388–988.
[9] 郑陈光, 覃靖, 杜娟, 陈科, 陈赤, 田晓先, 相蕾, 孙亮, 杨泽. 南宁地区唐氏综合征患者的细胞遗传学研究. 遗传, 2009, 31(3): 261–264.
[10] Wang X, Thomas P, Xue J, Fenech M. Folate deficiency-induces aneuploidy in human lymphocytes in vi-tro-evidenceusing cytokinesis-blocked cells and probes specific for chromosomes 17 and 21. Mutat Res, 2004, 551(1–2): 167–180.
[11] Fenech M. The role of folic acid and Vitamin B12 in ge-nomic stability of human cells. Mutat Res, 2001, 475(1–2): 57–67.
[12] Rai AK, Singh S, Mehta S, Kumar A, Pandey LK, Raman R. MTHFR C677T and A1298C polymorphisms are risk factors for Down's syndrome in Indian mothers. J Hum Genet, 2006, 51(4): 278–283.
[13] da Silva LR, Vergani N, Galdieri Lde C, Ribeiro Porto MP, Longhitano SB, Brunoni D, D'Almeida V, Alvarez Perez AB. Relationship between polymorphisms in genes in-volved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. Am J Med Genet A, 2005, 135(3): 263–267.
[14] Chango A, Fillon-Emery N, Mircher C, Blehaut H, Lam-bert D, Herbeth B, James SJ, Rethore MO, Nicolas JP. No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers. Br J Nutr, 2005, 94(2): 166–169.
[15] Takamura N, Kondoh T, Ohgi S, Arisawa K, Mine M, Ya-mashita S, Aoyagi K. Abnormal folic acid-homocysteine metabolism as maternal risk factors for Down syndrome in Japan. Eur J Nutr, 2004, 43(5): 285–287.
[16] Coppede F, Marini G, Bargagna S, Stuppia L, Minichilli F, Fontana I, Colognato R, Astrea G, Palka G, Migliore L. Folate gene polymorphisms and
/
| 〈 |
|
〉 |